Biopid wins approval for atopic skin disease drug

Published: 2012-11-08 06:57:00
Updated: 2012-11-08 06:57:00
A local biopharmaceutical company has won approval to produce a novel medicine for the topical treatment of atopic skin disease.

Biopid announced Tuesday that the Korea Food and Drug Administration approved its product Utoma solution after intensive studies of development.

Utoma induces th...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.